Saturday, October 31, 2026

Less Than Two Hours Before The NYSE Open, Mizuho Financial Group Is Down By 4%

ViaNews Editorial Team

February 6, 2023

Less Than Two Hours Before The NYSE Open, Mizuho Financial Group Is Down By 4%

(VIANEWS) - The NYSE opens in less than two hours and Mizuho Financial Group's pre-market value is already 4.75% down.

Mizuho Financial Group's last close was $3.16, 4.24% below its 52-week high of $3.30.

The last session, NYSE ended with Mizuho Financial Group (MFG) sliding 0.94% to $3.16. NYSE dropped 0.76% to $15,999.40, following the last session's downward trend on what was a somewhat down trend trading session.

About Mizuho Financial Group

Mizuho Financial Group, Inc., together with its subsidiaries, engages in banking, trust, securities, and other businesses related to financial services in Japan, the Americas, Europe, Asia/Oceania, and internationally. It operates through five segments: Retail & Business Banking Company, Corporate & Institutional Company, Global Corporate Company, Global Markets Company, and Asset Management Company. The company provides deposit products; syndicated, housing, and card loans; business matching services; and advisory services related to overseas expansions, and mergers and acquisitions-related services. It also offers consulting services, including asset management and asset succession; payroll services; and sells lottery tickets issued by prefectures and ordinance-designated cities. In addition, it offers financial solutions, such as bonds, mergers and acquisitions advisory, risk hedging products, etc. for corporate customers to meet their needs in fund-raising, investment management, and financial strategies; solutions based on their capital management, business strategy, and financial strategy; real estate agency services; advisory services and solutions, such as advice on proposals on various investment products to financial institutions; and financial services that include funding support and public bonds underwriting. Further, the company offers sales and trading services to meet needs for customers; investment products for individual customers; and consulting services for institutional investors. Additionally, the company provides products and services related to trust, securitization and structured finance, pension, and stock transfers; securities services; and research, private banking, and information technology-related services. Mizuho Financial Group, Inc. was incorporated in 2003 and is headquartered in Tokyo, Japan.

Earnings Per Share

As for profitability, Mizuho Financial Group has a trailing twelve months EPS of $0.2884.

PE Ratio

Mizuho Financial Group has a trailing twelve months price to earnings ratio of 10.94. Meaning, the purchaser of the share is investing $10.94 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.9%.

Yearly Top and Bottom Value

Mizuho Financial Group's stock is valued at $3.16 at 07:42 EST, under its 52-week high of $3.30 and way above its 52-week low of $2.10.

Moving Average

Mizuho Financial Group's worth is way above its 50-day moving average of $2.70 and way higher than its 200-day moving average of $2.41.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.1%, now sitting on 2.48T for the twelve trailing months.

Volume

Today's last reported volume for Mizuho Financial Group is 651975 which is 58.16% below its average volume of 1308620.

More news about Mizuho Financial Group (MFG).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com